C-NJL8BioChange ltd
foam scaffold, tissue repair, regenerative medicine
repairingtissue engineered
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-NJL8
C-NJL8C-NJL8foam scaffold, tissue repair, regenerative medicine
0-100 chain-logic scale · 15 dimensions · scored on public evidence
As our organs emerge at the initial embryonic phase, trillions of cells work together in perfect synchrony to execute an anatomical plan. They communicate via vibrations of the unique FOAM extra cellular matrix. As the tissues mature, the foam turns into fibers and the ability to regenerate damages greatly diminishes. At BioChange we introduce a biomimetic foam scaffold into the damaged tissue to reconnect the cells to the collective intelligence of the human body.
00:00:00 Dr. Ilia Stambler (Chairman, Vetek Association. Bar Ilan University) 00:00:40 Prof. Amnon Albek (Rector. Bar-Ilan University) 00:05:52 Prof. Michal Ben-Shachar (Chairperson. The Unit for Interdisciplinary Studies, Bar-Ilan University) 00:11:55 Dr. Noam Yuran (Chairman. Graduate Program in Science, Technology and Society, Bar-Ilan University) 00:17:08 Alex Friedman (Chairman. Disabled, Not Half a Person) 00:22:36 Iris Barner (British Council. Director for Israel) 00:28:50 Hanan Tal (CEO. Vetek Association) 00:34:08 Dr. Ilia Stambler (Chairman, Vetek Association. Bar Ilan University) 00:55:03 Prof. Valery Krizhanovsky (Weizmann Institute of Science) Senescent cells: where to find them and how to deal with them. 01:15:17 Prof. Alon Monsonego (Ben-Gurion University of the Negev) Cellular and molecular trajectories of age-associated lymphocytes and their impact on aging and cognitive decline. 01:41:18 Prof. Carmela R. Abraham (Advantage Therapeutics, Klothea Bio) Increasing K
דני רופ מראיין את ישי אתר מייסד BioChange
Ishay Attar, founder and CTO of BioChange, discusses how the company is transforming tissue regeneration. Ishay is a biomedical engineer and a serial entrepreneur in biomaterials and medical devices. Learn more about BioChange: https://biochange.life Ishay’s LinkedIn profile: https://www.linkedin.com/in/ishay-attar-954196/ About quadraScope Ventures ------------------------------------------------ quadraScope is a venture fund in Boston focusing on the emerging longevity healthcare market. We invest in companies developing pharmaceuticals, diagnostics, software, equipment and devices enabling disease treatment and prevention through biological age reversal. To learn more, please visit our website https://www.quadrascope.com. #longevity #healthcare #aging #bioengineering #biomaterials
Ishay Attar discusses the work being done by BioChange. Growing Younger Transforming tissue regeneration
BioChange BioChange invented a tissue scaffold which restores cellular communication to the level it was at the embryonic stage, enabling cells to rebuild damaged tissues and organs, restoring youth and functionality. Speaker: Ishay Attar – Founder, Chairman and CTO, CSO – BioChange The Longevity Sciences Industry is multi-faceted, with new approaches being explored globally. Key segments include: Senolytics and Senescence: These focus on removing or rejuvenating senescent cells, which accumulate with age and contribute to various age-related diseases. Telomere Research: Telomeres, protective caps at the end of chromosomes, play a role in cellular aging. Research aims to maintain or lengthen telomeres. Metabolic Interventions: Caloric restriction, intermittent fasting, and mimetics (such as resveratrol) target metabolic pathways to promote longevity. Epigenetics: Understanding how gene expression changes with age and finding ways to modulate it for healthier aging. Stem Cell Thera
Foam of Life: stimulating tissues to regenerate and repair with a 3D foam structure | Ishay Attar, Biochange Presentation at: Advances in 3D Bioprinting September 10th - 12th, 2023
Foam of Life: stimulating tissues to regenerate and repair with a 3D foam structure | Ishay Attar, Biochange Presentation at: Advances in 3D Bioprinting September 10th - 12th, 2023
Ishay Attar is a biomedical engineer and serial entrepreneur in biomaterials and medical devices. He is the founder and CEO of BioChange, a quadraScope portfolio company working on soft tissue regeneration. BioChange engineered injectable or implantable biomaterials that replicate the foam-like environment where cells grow in embryos, providing a scaffold where cells can attach and grow. Learn more about BioChange: https://biochange.life Learn more about quadraScope: https://quadrascope.com Ishay’s LinkedIn profile: https://www.linkedin.com/in/ishay-attar-954196/ José’s LinkedIn profile: https://www.linkedin.com/in/jose-navarro-betancourt/ #longevity #biotechnology #aging #bioengineering #biomaterials
Created by InShot https://inshotapp.page.link/YTShare
www.biochange.life
www.biochange.life
for more info: www.biochange.life [email protected]
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
57536 GEF Country Portfolio Evaluation: Benin (1991�2007) OctOber 2008 Evaluation Office G LOBAL ENVIRONMENT FACILITY Global Environment Facility Evaluation Office GEF Country Portfolio Evaluation: Benin (1991�2007) October 2008 (The main findings and recommendations of this evaluation were presented to the GEF Council in April 2008.) Evaluation Report No. 41 (English) � 2008 Global Environment Facility Evaluation Office 1818 H Street, NW Washington, DC 20433 Internet: www.gefeo.org Email: [email protected] All rights reserved. The findings, interpretations, and conclusions expressed he … applicable law. The GEF encourages dissemination of its work and will normally grant permission promptly. ISBN-10: 1-933992-12-3 ISBN-13: 978-1-933992-12-9 Credits Director of the GEF Evaluation Office: Robert D. van den Berg Task Manager: Sandra Romboli, Evaluation Officer, GEF Evaluation Office Evaluation Team: Alain Lafontaine (Team Leader) and Paul Onibon, consultants Editing and design: Nita Congress Cover photo: Marine ecosystems in Avlekete, by Sandra Romboli Evaluati … AO Food and Agriculture Organization Management Project (Programme FNE National Fund for the Environment Cadre pour la Gestion des Patrimoines (Fonds National pour l'Environnement) Nationaux) xi PGFTR Program for the Management of Forests UNCCD United Nations Convention to Combat and Adjacent Lands (Projet de Gestion Desertification des For�ts et des Terroirs Riverains) UNDP United Nations Development PGRN Natural Resource Management Project Programme (Projet de Gestion des R … nstrated ongoing global environmental strategies, and action plans, in order to apply these impacts years after GEF support ended in their conventions through a range of enabling activities, respective focal areas, such as, climate change the country is poised to implement the conven- (from carbon sequestration) and biodiversity tions and mobilize the capacities developed. This (from species conservation), in the Pendjari Bio- will be a much greater challenge in a country lik … ith others. to the activities of the GEF and its executing Different modalities apply to the development and agencies, such as country assistance strategies approval of regional and global projects. Given or mechanisms, and project evaluations and the time and financial resources available to con- reviews (annex C includes a bibliography of the d
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
SAb Biotherapeutics Rebrands as SAB BIO | SABS Stock News --> STOCK TITAN Login Sign up Login Sign up 0 HOME --> NEWS FEED Stock News Live Stock News Today Trending News AI news FDA Approvals Clinical Trials Crypto News Merger & Acquisitions Earnings Offerings IPO News Stock Splits Top News - Gainers Top News - Losers SEC FILINGS SEC Filings Live SEC Filings Today Form 4 - Insider Trading 8-K - Material Events 10-K - Annual Reports 10-Q - Quarterly Reports DEF 14A - Proxy Statements S-1 - IPO Registration S-3 - Shelf Registration STOCKS All Stock Themes AI Stocks Crypto Stocks Oil & Gas Defens
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Top 50 Biotech Angel Investors in Middle East (June 2026) | Shizune 300+ investors in your industry, stage, and region Get Biotech Any industry Artificial Intelligence Google EdTech Clean Energy Retail Enterprise Software Local Travel Platforms InsurTech Oil and Gas Cryptocurrency Social Impact SaaS Film Restaurants Photography Payments Renewable Energy Organic Food Email Fitness CleanTech Energy Health Care Machine Learning Agriculture (AgTech) Marketplace Gaming Facebook Social Network Blockchain B2B Big Data Video Games Education Wellness Medical Device Mobile Legal Sports Construction Auto … Medical, Robotics, Biotechnology Ozlem Tumer Eke Angel 2 Turkey Seed, Pre-Seed, Grant Biotechnology, AgTech, Beauty $850k–$2M Naci Topçuoğlu Angel 2 Turkey Seed, Angel, Convertible Note Retail, Analytics, Biopharma $1M–$2.5M Kaan Akın Angel 1 Demir Karaaslan Angel 1 Turkey Seed, Angel Biotechnology, Sustainability, Natural Resources Yalin Karadogan Angel 1 Turkey, Germany Seed Software, AgTech, Energy Yasemin Mistikoglu Angel 1 Turkey Grant AgTech, Life Sc … ded First Round Capital with Josh Kopelman as the first professional Seed Stage Fund, where he remains Senior Advisor. Prior to First Round, Howard helped found Idealab with Bill Gross, and served as President of Renaissance Technologies, which he co-founded with Jim Simons. Prior tohis move into the business of technology, Howard served as a professor at the Wharton School and the Moore School, both at the University of Pennsylvania, as well as at Cornell University. He is a … ktivate provides a SaaS based tecnology platform for K-12 schools to manage and fund scholastic sports. The system features administration and engagement tools to bring together student-athletes, their families, schools, and valued partners. NeuroKaire — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster. HATCH — HATCH is the first of it … lectrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches. Epitomee Medical — Epitomee develops paradigm-shifting ingestibledevices that deploy targeted therapies along the GI tract Show all investments... Access 48,091 investors 822 industries, 177 countri
%PDF-1.5 %���� 25225 0 obj > endobj 25234 0 obj >/Filter/FlateDecode/ID[ ]/Index[25225 22]/Info 25224 0 R/Length 70/Prev 5449066/Root 25226 0 R/Size 25247/Type/XRef/W[1 3 1]>>stream h�bbd```b``�� � ��D�H�HfO�& H2����/�����$���$�3̏�`�� endstream endobj startxref 0 %%EOF 25246 0 obj >stream h��U�oE�w{���t�`h��8�{��C-�b�����zm�B�V)�^m5!s���m�� ��RD� _É�� �*�&&m��?�h�I�Ͷ`"���ٙy��g���f�v��w3X�W! �y��g�&�L�E֑�(`{!��ɔ�a�4� "��Ϣ�G�+�w��&w�瓅�^�3�L����V��Ͻ7�?��1R��Z�_�wG��[v@�Y{ ����Ik/�qP�`�ػ�pt� X��p¿�e�Rwc�HVv,9nW�[�n���Q����[�w�WS^�W�s�x���{KA � ��nk��v���E�[� … >stream 2022-10-25T17:29:03+02:00 2022-10-28T07:51+02:00 2022-10-28T07:51+02:00 application/pdf uuid:63cfe264-d709-477d-9114-1b5c542d3325 uuid:c021d005-9752-49a9-9e29-6c8da99748e4 endstream endobj 569 0 obj >stream h�4��JAEe�`�n�a���D�L 1Qa5��]�N�����ř;�R��v:�w_��?[��� o�g�:��y��x����u7"��q%��\���e���}t���ۋ�.F���XF��j�iF�oh �y��!���F��ndF����o��az��!&���Д�����M��s �� nc}%����Ϝ��@cTQ�;������ ��u���:\�pn����2p� l:�§�)| �§�)| �§�)|jeu��"��$��^���( >strea
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Shiba Inu: Shytoshi Kusama's Silence on X Lingers, Break Coming Soon? — TradingView News Search Products Community Markets Brokers More EN Get started News / U.Today / Shiba Inu: Shytoshi Kusama's Silence on X Lingers, Break Coming Soon? Shiba Inu: Shytoshi Kusama's Silence on X Lingers, Break Coming Soon? 1 min read SHIBUSD Shiba Inu lead ambassador Shytoshi Kusama 's silence on social media continues to linger. The Shiba Inu lead ambassador has stayed off X in recent weeks, neither tweeting, commenting nor interacting with posts. Kusama's last visible activity on X wa
USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System United States Patent and Trademark Office Home | Site Index | Search | Guides | Contacts | e Business | eBiz alerts | News | Help TTABVUE. Trademark Trial and Appeal Board Inquiry System v2.8.0 Summary Query: Correspondence Name contains all words: DAVID C. PURDUE PURDUE LAW Number of results: 100+ Results are in reverse chronological order Page #1. Go to page: 2 3 4 5 Next Proceeding Filing Date Defendant(s), Correspondent Property(ies) Plaintiff(s), Correspondent Property(ies) 79328586 06/05/2023 Maria Clementine Martin Klosterfr
Shifted distribution baselines: neglecting long-term biodiversity records risks overlooking potentially suitable habitat for conservation management Shifted distribution baselines: neglecting long-term biodiversity records risks overlooking potentially suitable habitat for conservation management Philos Trans R Soc Lond B Biol Sci . 2019 Dec 23;374(1788):20190215. doi: 10.1098/rstb.2019.0215. Epub 2019 Nov 4. Authors Sophie Monsarrat 1 2 3 , Peter Novellie 1 , Ian Rushworth 4 , Graham Kerley 1 Affiliations 1 Centre for African Conserv
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Team BioChange Makers is featured in the Video Submission Round of Hult Prize at Khulna University 2026. This video presents the team’s proposed idea and approach to addressing a contemporary social challenge through innovation and responsibility. We request everyone to watch and share this video via the official Hult Prize at Khulna University page and support the initiative. | Hult Prize at Khulna University
%PDF-1.5 %���� 1 0 obj >>> endobj 2 0 obj > endobj 3 0 obj >/XObject >/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 595.32 841.92] /Contents 4 0 R/Group >/Tabs/S/StructParents 0>> endobj 4 0 obj > stream x��ZYo�F~ `� ��n�}����I6�q6A 8-3#�I{��ut7����9l�쮻��j�껦��e|���w]W, �U���]������cy�s��vEWջo� ����w�_]���Xw��_�A���F$I�d�P�����(X���_� �?���~��o� �f�^�]Wo��v�.�TdY`2e�o�e�T��H��ҿP�X�$ �(� t,tД�_��U�;c���Q�Hk!����=K��*c�4���j�g��6ǘ�s�q,������ӌ\~�H:�"J-Y�-�����X5�O�E|�A�L⏳�lf%Hz���Ĺ�D��6�+��I'h"ń�Qr$B��@��v[��4xS�ش �~Ƅ����M]�P��AX�.�_/F�+�ɛJ2[�&6y��v
BioChange News and Press Releases | PR Newswire Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company English-only News Releases Overview Multimedia Gallery All Multimedia All Photos All Videos Multimedia Gallery Overview Trend … ated to make your job easier. In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need. LEARN MORE « 1 --> 1 » Making a selection with these dropdown will cause content on this page to change. News listings will update as each option is selected. Items per page: 25 per page 50 per page 75 per page 100 per page Contact PR Newswire Call PR Newswire at 888-776-0942 from 8 AM - 9 PM ET Chat with an Expert Contact Us … tform Login ProfNet Data Privacy Do not sell or share my personal information : Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Platform Login ProfNet Call PR Newswire at 888-776-0942 Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookies Copyright © 2026 Cision US Inc. --> -->
#regum #regum #biochange #regum #regum | BioChange Ltd. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Polic … ias Cohen jerzy gawor Ishay Attar 2y Edited We won the BEST POSTER PRESENTATION AWARD! out of 1200 posters presented recently at the World Biomaterials Congress in Korea. Two years ago, leading researchers conducted a canine study comparing BioChange Ltd. ’s ReGum with standard care treatment for periodontal disease. The results, published in Frontiers, showed a 100% improvement using our product in recovering lost gingival tissue and bone. Even more experimental data was add … our employees Keren Sinik and Shani Attias Cohen . Receiving such a prestigious award is an encouraging acknowledgment of the scientific value of our work. #biomaterials #periodontitis #RegenerativeMedicine #WorldBiomaterialsCongress #regum #cellfoam #WBC #WBC2024 7 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in 1,917 followers View Profile Connect Explore content categories Career Productivity Finance Soft Skills & Emotional Intelligence Pr
Bio-Change, Ltd. | MTEC MTEC Focus Areas Who we serve Solicitations Patents About Us Explore Join MTEC Log In Life Sciences / Companies Bio-Change, Ltd. BioChange is dedicated to advancing tissue repair and regeneration through innovative technologies. Their flagship CellFoam™ technology provides a natural protein foam scaffold that supports cell growth and tissue repair, with applications in both veterinary and human medicine. The company aims to address unmet medical needs and improve overall well-being by developing products that facilitate natural healing processes. Industries biotechnolog
Medicine is acting like a... - Israel Innovation Authority Facebook Log In Israel Innovation Authority's Post Israel Innovation Authority April 12 · Shared with Public Medicine is acting like a master builder by patching damage while also reconstructing living tissue from the ground up BioChange is advancing the future of regenerative healthcare. BioChange is a biotech company operating in the field of regenerative medicine, one of the most advanced and impactful areas shaping the future of healthcare. Led by CEO Iris Shoor, the company is another strong example of women driving innovatio
PLANT·EVOLUTION·&·DIVERSIFICATION - Home Home People Research Publications Management & Resources Dissemination & Outreach Journal clubs Teaching Opportunities Menu Home People Research Publications Management & Resources Dissemination & Outreach Journal clubs Teaching Opportunities Biological Conservation & Evolution in the Genomic era > Purchase Logo To Remove Watermark Contact WELCOME! ​ Biological Conservation and Evolution in the Genomic era ( BioChange ) is an initiative leaded by a group of collegues and friends working in many aspects of different bi
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
%PDF-1.4 %���� 7040 0 obj > endobj xref 7040 30 0000000016 00000 n 0000003354 00000 n 0000003559 00000 n 0000003620 00000 n 0000005687 00000 n 0000006452 00000 n 0000007306 00000 n 0000007876 00000 n 0000008150 00000 n 0000008754 00000 n 0000009016 00000 n 0000009635 00000 n 0000010430 00000 n 0000012748 00000 n 0000014608 00000 n 0000016731 00000 n 0000018874 00000 n 0000020611 00000 n 0000022869 00000 n 0000025018 00000 n 0000027220 00000 n 0000045509 00000 n 0000058417 00000 n 0000093994 00000 n 0000094035 00000 n 0000098997 00000 n 0000099038 00000 n 0000101063 00000 n 0000003063 00000 n 0 … g8�� � �2��79�~�6�wQ7f�� }��Eht�#��*�b� |�sY~C�ė8+W�U} ��bp~�þ(F >stream application/postscript Print Hreinn Gudlaugsson 2017-09-28T10:39:42+02:00 2017-09-28T10:39:42+02:00 2017-09-28T10:39:42+02:00 Adobe Illustrator CC 2017 (Windows) xmp.iid:62ab3eb4-31e7-6044-8907-9c63b7fa8c11 xmp.did:62ab3eb4-31e7-6044-8907-9c63b7fa8c11 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:ccaee6f2-396c-6f46-9e99-e0a8d1e54abf xmp.did:ccaee6f2-396c-6f46-9e99-e0a8d1e54abf uuid:5D208 … Adobe PDF library 10.01 endstream endobj 7063 0 obj > endobj 7064 0 obj >stream application/postscript 8000 0/0/0/0 Hreinn Gudlaugsson Adobe Illustrator CS5 2011-08-26T13:02:31+02:00 2011-08-26T13:02:31+02:00 2011-08-26T13:02:31+02:00 xmp.did:540BFDE4D2CFE011A8CA90190BBAC861 xmp.iid:540BFDE4D2CFE011A8CA90190BBAC861 uuid:903E154FA4F2DD1185EEB012C6C475E9 proof:pdf uuid:884c9dde-19c4-40d6-b69e-df8f1bd235b6 xmp.did:26980DCFC0F9DD1195B09E350987EC84 uuid:903E154FA4F2DD1185EEB012C6C … obj 6 0 obj >stream {0 exch } endstream endobj 7 0 obj > endobj 8 0 obj >stream application/pdf Villum Fonden 9.9_CMYK_HG Adobe Illustrator 24.1 (Windows) 2020-04-14T10:10:58+02:00 2020-04-14T10:10:58+02:00 2020-04-14T10:10:58+02:00 xmp.did:42a266a0-a660-aa43-aad6-42c251aa3359 uuid:676b0658-c447-49f7-ac51-2c88193cf3e2 uuid:FAB0C46386CD11DEBA72FCCABB114ECE proof:pdf xmp.iid:45223cae-c697-0347-bdd7-65fc7bb3f963 xmp.did:45223cae-c697-0347-bdd7-65fc7bb3f963 uuid:FAB0C46386CD11DEB … -bdd7-65fc7bb3f963 uuid:FAB0C46386CD11DEBA72FCCABB114ECE default converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:F97F117407206811871F9F75FAB6E6E3 2014-03-05T01:25:15+01:00 Adobe Illustrator CS5 / saved xmp.iid:42a266a0-a660-aa43-aad6-42c251aa3359 2020-04-14T10:10:57+02:00 Adobe Illustrator 24.1 (Windows) /
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Ishay Attar — Grokipedia Search ⌘K Suggest Edit Sign in Sign in Education Degrees from the Technion Focus areas in biomedical engineering and entrepreneurship Career LifeBond BioChange OutSense Eximore Contributions to biomedicine Regenerative medicine and tissue engineering Biosurgery and surgical innovations Non-invasive health diagnostics Longevity and aging research interests References Fact-checked by Grok 5 months ago Ishay Attar Ara Eve Leo Sal 1x Ishay Attar is an Israeli biomedical engineer and serial entrepreneur specializing in healthcare technology, with a focus on regenerative med … eation, equipping him with skills to bridge scientific research with commercial application in the biomedical sector. This combination of technical depth in biomedical fields and business acumen prepared him for leadership in healthcare innovation. [2] This interdisciplinary academic focus laid the groundwork for his subsequent work in regenerative medicine and diagnostic technologies. Career LifeBond LifeBond was co-founded by Ishay Attar in 2007 alongside Orahn Preiss-Bloom … ogy involves in situ gel-forming sealants that achieve rapid cross-linking upon application, forming durable seals capable of withstanding substantial pressures (up to 200 mmHg in burst tests on porcine skin) while supporting natural tissue healing. These materials are designed to prevent fluid leakage and control bleeding in various procedures, including gastrointestinal anastomoses , vascular repairs , and other surgeries prone to postoperative leaks or hemorrhage. In vivo … , and breakthroughs are ideal Search first to check if it already exists Cancel Submit Summary Edit content (optional) Supporting sources (optional) Add another source What makes a great edit? Select the wrong text in the article first Add a source link so we can verify One fix per submission is easiest to review Cancel Submit Edit Something went wrong We couldn't submit your suggestion. Please try again. Try again Thank you! Grok will review your suggestion and add the artic … review your suggestion and add the article if it sees fit. View my suggestions Submit another suggestion
10-K false 0001541157 FY 1 1 http://fasb.org/srt/2024#ChiefExecutiveOfficerMember http://fasb.org/us-gaap/2024#RestructuringCosts two years 1 1 http://fasb.org/srt/2024#ChiefExecutiveOfficerMember 0001541157 us-gaap:PatentsMember 2024-01-01 2024-12-31 0001541157 us-gaap:DomesticCountryMember 2023-12-31 0001541157 sic:Z8880 aktx:PeakBioMember 2024-11-14 0001541157 aktx:NovemberTwoThousandTwentyTwoWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-12-31 0001541157 aktx:TwoThousandTwentyOneNotesMember 2024-01-01 2024-12-31 0001541157 aktx:SeriesBWarrantsMember 2023-01-01 2023-12-31 0001 … eding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” … or operating profits. • We will require substantial additional capital to fund our operations, and if we are unable to obtain such capital, we will be unable to successfully develop and commercialize any product candidates. • We have identified material weaknesses in our internal control over financial reporting. • We have not initiated clinical studies for any of the programs in our active pipeline or entered into any strategic partnerships regarding the co … countries, or any patent term extensions that might be available following the grant of marketing authorizations. We have pending patent applications for our product candidate nomacopan and its uses that, if issued, would expire in the United States and in countries outside of the United States between 2024 and 2040, excluding any patent term adjustment that might be available following the grant of the patent and any patent term extensions that might be available following … the patent and any patent term extensions that might be available following the grant of marketing authorizations. These patent and patent applications relate to subject matters including: complement inhibitor molecule; methods for treating myasthenia gravis; methods for treating peripheral nerve disorders; methods for treating respiratory disord
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
tinymce.css --> BioChange | Environmental Protection Agency Skip to main content Open mobile menu Close mobile menu Environment & You Skip to Our Services tab Air Climate change Circular Economy Drinking water Freshwater and Marine Noise Radiation Radon Wastewater Environment & You Explore your relationship with the environment and action you can take. Our Services Skip to Publications tab Licensing & Permitting Air Climate Change Freshwater & Marine Genetically Modified Organisms Industrial Emissions Licensing (IED) Integrated Pollution Control (IPC) Licensing Radiation Waste … las Faoin EPA Who We Are Learn more about the EPA and how to contact us. Search Submit search Please enable JavaScript to use Site Search Search for a licence or permit Home Publications Research Biodiversity BioChange BioChange Synthesis Report for project 2005-CD-B2-M1 Summary: Biodiversity and Environmental Change: An Integrated Study Encompassing a Range of Scales, Taxa and Habitats Published: 2011 ISBN: 978-1-84095-392-3 Pages: 60 Filesize: 1,279 KB Format: pdf Download
Purim, Ironman & entire limb regeneration: During this past week we celebrated Purim at BioChange Ltd. But this year our happiness was handicapped by the atrocities of war. In the spirit of the… | Ishay Attar LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at an
%PDF-1.7 %���� 1050 0 obj > endobj xref 1050 34 0000000016 00000 n 0000003485 00000 n 0000003661 00000 n 0000003722 00000 n 0000004827 00000 n 0000005598 00000 n 0000006448 00000 n 0000007008 00000 n 0000007047 00000 n 0000007162 00000 n 0000007436 00000 n 0000008024 00000 n 0000008286 00000 n 0000008923 00000 n 0000009187 00000 n 0000009971 00000 n 0000012272 00000 n 0000014085 00000 n 0000016178 00000 n 0000018295 00000 n 0000020061 00000 n 0000022265 00000 n 0000024601 00000 n 0000026616 00000 n 0000029267 00000 n 0000046199 00000 n 0000059251 00000 n 0000077762 00000 n 0000113337 00000 n 0 … Y���C{���u�G,�[S1�����~8Z������_+�A� endstream endobj 1077 0 obj >stream application/postscript Print Hreinn Gudlaugsson 2017-09-28T10:39:42+02:00 2017-09-28T10:39:42+02:00 2017-09-28T10:39:42+02:00 Adobe Illustrator CC 2017 (Windows) xmp.iid:62ab3eb4-31e7-6044-8907-9c63b7fa8c11 xmp.did:62ab3eb4-31e7-6044-8907-9c63b7fa8c11 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:ccaee6f2-396c-6f46-9e99-e0a8d1e54abf xmp.did:ccaee6f2-396c-6f46-9e99-e0a8d1e54abf uuid:5D208 … Adobe PDF library 10.01 endstream endobj 1078 0 obj > endobj 1079 0 obj >stream application/postscript 8000 0/0/0/0 Hreinn Gudlaugsson Adobe Illustrator CS5 2011-08-26T13:02:31+02:00 2011-08-26T13:02:31+02:00 2011-08-26T13:02:31+02:00 xmp.did:540BFDE4D2CFE011A8CA90190BBAC861 xmp.iid:540BFDE4D2CFE011A8CA90190BBAC861 uuid:903E154FA4F2DD1185EEB012C6C475E9 proof:pdf uuid:884c9dde-19c4-40d6-b69e-df8f1bd235b6 xmp.did:26980DCFC0F9DD1195B09E350987EC84 uuid:903E154FA4F2DD1185EEB012C6C … � �KY��� �rB ��a�w��}� T_���� ��m{q��e�1�n��p$�$�w>�s��!�X��x���� >stream application/pdf Villum Fonden 9.9_CMYK_HG Adobe Illustrator 24.1 (Windows) 2020-04-14T10:10:58+02:00 2020-04-14T10:10:58+02:00 2020-04-14T10:10:58+02:00 xmp.did:42a266a0-a660-aa43-aad6-42c251aa3359 uuid:676b0658-c447-49f7-ac51-2c88193cf3e2 uuid:FAB0C46386CD11DEBA72FCCABB114ECE proof:pdf xmp.iid:45223cae-c697-0347-bdd7-65fc7bb3f963 xmp.did:45223cae-c697-0347-bdd7-65fc7bb3f963 uuid:FAB0C46386CD11DEB … -bdd7-65fc7bb3f963 uuid:FAB0C46386CD11DEBA72FCCABB114ECE default converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:F97F117407206811871F9F75FAB6E6E3 2014-03-05T01:25:15+01:00 Adobe Illustrator CS5 / saved xmp.iid:42a266a0-a660-aa43-aad6-42c251aa3359 2020-04-14T10:10:57+02:00 Adobe Illustrator 24.1 (Windows) /
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
ReGum scientifically proven to heal gum recession | Dentistry33 VECCHIO window.googletag = window.googletag || {cmd: []}; googletag.cmd = googletag.cmd || []; var dfpslots=[]; $(document).ready(function(){ dfpslots.push($("#div-gpt-ad-header")); dfpslots.push($("#div-gpt-ad-manchette")); dfpslots.push($("#div-gpt-ad-boxdx")); dfpslots.push($("#div-gpt-ad-tower")); dfpslots.push($("#div-gpt-ad-1612890712879-0")); var headerMapping=googletag.sizeMapping() .addSize([992,0],[[970,90],[728,90],[1,1],'fluid']) //desktop .addSize([768,0],[[728,90],[1,1],'fluid']) //tablet .addSize([320,0],[[320,50],[
%PDF-1.6 %���� 4186 0 obj > endobj 4226 0 obj >/Filter/FlateDecode/ID[ ]/Index[4186 115]/Info 4185 0 R/Length 169/Prev 12420841/Root 4187 0 R/Size 4301/Type/XRef/W[1 3 1]>>stream h�bbd```b`�j��� �AD� �� �i ���"9��H�B��'X�LB���5@d(X�n>�d|�6'��%� �f�eJ�{��� �`�E7�� ��Xv\��� ,2,�"�ށE&"D���"S�$K�> ��|#��+�OG:�|uȸ�?�'�'�C � endstream endobj startxref 0 %%EOF 4300 0 obj >stream h��V�WS�nr�I�=B�Y!6�X�R��[��&@!|#�> �h�r2�� �� ���&�:%@�H邹��/�~z��u��y���Y����1��nx�o���Cv�]�4���� ���P���0�>�}N��S�R\�%���疉�z�(��xO=��om:���!���]�/����s^��_��ڋ��^��۽�����V � [�}�/ … ����>��6[W 6���: ���)pɐ�^��3۰�v������y%�7 endstream endobj 5 0 obj >stream application/postscript DFF_Logo_DKENG_Black Lasse Stragaard Adobe Illustrator CC 2017 (Macintosh) 2017-06-01T15:57:29+02:00 2017-06-01T15:57:29+02:00 2017-06-01T15:57:29+02:00 proof:pdf uuid:65E6390686CF11DBA6E2D887CEACB407 xmp.did:fd876514-9a6e-4a52-bc85-9a3bee28d4e1 xmp.iid:fd876514-9a6e-4a52-bc85-9a3bee28d4e1 uuid:8d957f52-207d-5741-b147-51e42917397c xmp.did:b8e0b218-b382-42b8-957c-2f5cd79254ee … 713 11.584649 0.000000 Adobe PDF library 15.00 endstream endobj 6 0 obj >stream application/postscript Carlsberg Foundation Thomas Wichmann 2012-08-23T10:47:23+02:00 2012-08-23T10:47:23+02:00 2012-08-23T10:47:23+02:00 Adobe Illustrator CS5 xmp.iid:48B993DF122068118A6DB774DA97A1B4 xmp.did:48B993DF122068118A6DB774DA97A1B4 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:08801174072068118A6DB774DA97A1B4 xmp.did:08801174072068118A6DB774DA97A1B4 uuid:5D20892493BFDB11914A859 … 18C14887630C03712 2012-05-24T10:25+02:00 Adobe Illustrator CS5 / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:08801174072068118C14887630C03712 2012-05-24T10:35:34+02:00 Adobe Illustrator CS5 / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:F97F1174072068118C14A15A9905A175 2012-06-26T10:00:35+02:00 Adobe Illustrator CS5 / converted from application/postscript to application/vnd.adobe.illustra … 6DB774DA97A1B4 2012-08-23T10:29:34+02:00 Adobe Illustrator CS5 / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:48B993DF122068118A6DB774DA97A1B4 2012-08-23T10:47:23+02:00 Adobe Illustrator CS5 / Print False False 1 419.999514 296.999959 Millimeters Cyan Magenta Yellow Black Default Swatch Group 0 White CM
Ishay Attar Speaking Profile | The Gazebo- Speaker Directory About Explore Events Solutions Explore Events Write Review Learning Hub Solutions Speakers by Categories Top Rated Speakers Log in Sign up Speakers by Categories Top Rated Speakers Speaker Directory Home Pharma and Healthcare Profile Contact Ishay Ishay Attar CEO & Founder BioChange Ltd Country or State Israel Bio Current Position Degrees Past Talks Skills Bio I am a biomedical engineer and an accomplished serial-entrepreneur, inventor and venture creator. Now focused on the reversal of aging and solving tissue degeneration. Foun
BioChange - 2026 Company Profile, Team, Funding & Competitors - Tracxn JavaScript is disabled in your browser. enable it to enjoy the full features of Tracxn. Your browser was unable to load all of Tracxn resources. They may have been blocked by your firewall, proxy or browser configuration. Press Ctrl+F5 or Ctrl+Shift+R to have your browser try again and if that doesn't work, click here to retry or mail us at [email protected] Internal Server Error Toggle navigation Customers Investment Industry Venture Capital Funds Private Equity Funds Accelerators & Incubators Investment Banks Cor … r 2017 Location Yokneam Illit, Israel Stage Funding Raised Latest Funding Round Grant (prize money), Aug 31, 2017 , $***** Investors EIC Fund & 1 more Ranked 33 rd among 99 active competitors Employee Count 17 as on May 31, 2026 Similar Companies Humacyte & 112 more View BioChange's full profile Sign up to download BioChange's company profile Sign Up for Free BioChange's funding and investors BioChange has raised funding over 3 round s . Its first fundi … . Its first funding round was on Jan 03, 2017 . Its latest funding round was a Grant (prize money) round on Aug 31, 2017 for $ ***** . 1 investor participated in its latest round. BioChange has 2 institutional investor s . Here is the list of recent funding rounds of BioChange : Date of Funding Funding Amount Round Name Post-Money Valuation Revenue Multiple Lead Investors Other Investors Aug 31, 2017 1775713 Grant (prize money) 8278638 3022751 7518630 2309172 Mar 01, 2017 25 … 775713 Grant (prize money) 8278638 3022751 7518630 2309172 Mar 01, 2017 2523664 Grant (prize money) 4920429 7432245 1771725 Europa Jan 03, 2017 6302208 Grant (prize money) 6500359 1593637 4991184 Europa Access funding benchmarks and valuations. Sign up today! View details of BioChange 's funding rounds and investors BioChange's founders and board of directors Founder? Claim Profile The founders of BioChange is Ishay Attar . Ishay Attar is the CEO of BioChange . Here … sed Provider of tissue regeneration technology to stimulate tissue repair - EIC Fund , Europa 38/100 Get insights and benchmarks for competitors of 2M+ companies! Sign up today! Looking for more details on BioChange 's competitors? Click here to see the top ones BioChange's Investments and acquisitions BioChange has made no investments
BioChange Ltd. | The Org Platform Enrich Pricing Log in Sign up BioChange Ltd. 0 followers BioChange has developed a breakthrough technology for tissue regeneration. A unique injectable scaffold that stimulates tissue repair and remodelling at the injected site. The scaffold is based on natural biomaterials designed for implantation using a minimally invasive procedure. It mimics the heal... Read more Industries Biotechnology , Health Care Headquarters Yoqne`am `illit, Israel Employees 11-50 Links Org chart Teams Offices Positions ( 17 ) Unverified Org chart IA Ishay Attar Founder & CEO
BIOCHANGE BIOCHANGE Home Research Team Publications & output Research highlights Projects Events Contact Home Research Team Publications & output Research highlights Projects Events Contact Biogeographical Change and Predictive Modelling BIOCHANGE brings together a team of researchers working on assessing the spatial responses of species and ecosystems to global change, with a focus on biological invasions, climate change and land use dynamics. Read more about our research topics on the research page and check our publications and news below to follow our a
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Collagen | TREA Membership Tour Register Log in Collagen Follow Industry CPC A61L27/24 This industry / category may be too specific. Please go to a parent level for more data Parent Industries A HUMAN NECESSITIES A61 Medical science A61L METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL DISINFECTION, STERILISATION, OR DEODORISATION OF AIR CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES A61L27/00 Materials for grafts or prostheses or for coating grafts or prostheses Current I … log in for detailed analytics Patents Grants last 30 patents Information Patent Grant Cell-support matrix having narrowly defined uniformly vertically an... Patent number 12,344,860 Issue date Jul 1, 2025 Ocugen, Inc. Robert Lane Smith A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE Information Patent Grant Use of stem cells produced by stem cell generator in treatment of h... Patent number 12,343,448 Issue date Jul 1, 2025 East China University of Science and Technology Changshe … y Changsheng Liu A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE Information Patent Grant Prosthetic heart valves Patent number 12,343,254 Issue date Jul 1, 2025 Corvivo Cardiovascular, Inc. Robert G Matheny A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE Information Patent Grant Biologic filler for restoring and regenerating tissue Patent number 12,343,450 Issue date Jul 1, 2025 GENIPHYS, INC. Sherry L. Voytik-Harbin A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE Information Patent Gra … ed Paul Anderson A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE Information Patent Grant Optical tissue measurement Patent number 12,329,634 Issue date Jun 17, 2025 Edwards Lifesciences Corporation Carolyn Sue Martinez A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE Information Patent Grant Magnetically templated tissue engineering scaffolds and methods of... Patent number 12,318,509 Issue date Jun 3, 2025 University of Florida Research Foundation, Inc. Carlos Rinaldi A61 - MEDICAL … . Carlos Rinaldi A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE Information Patent Grant Surgical attachment device Patent number 12,318,275 Issue date Jun 3, 2025 TELA Bio, Inc. E. Skott Greenhalgh Y10 - TECHNICAL SUBJECTS COVERED BY FORMER USPC Information Patent Grant Method for manufacturing ring-shaped bone grafting substitute Patent number 12,
IMCAS - Congresses on Dermatology and Aesthetic & Plastic Surgery Ishay ATTAR Industry representative Israel Connect Biography BioChange is an innovator in the field of tissue engineering. Over the past 4 years we have developed a biodegradable injectable tissue scaffold, aimed to stimulate collagen production and provide long term tissue regeneration. The lab and animal clinical studies showed safety and significantly superior efficacy compared to any other injectable technology in the market. On approval our product will be a game changer in aesthetic dermatology. Read more Main in … 27 IMCAS Americas 2027 About The IMCAS story Scientific Partners Feedback IMCAS Fund Discover IMCAS Academy Webinars Library Insider magazine Podcasts Follow IMCAS Need assistance? Contact us Read FAQs Privacy policy Legal information © 2026 IMCAS International Master Course on Aging Science. All rights reserved. Accessibility : non-compliant Congresses IMCAS Asia 2026 IMCAS China 2026 IMCAS World 2027 IMCAS Americas 2027 Discover IMCAS Academy Webinars Library Insider magazi … ider magazine Podcasts About The IMCAS story Scientific Partners Feedback IMCAS Fund Need assistance? Contact us Read FAQs Privacy policy Legal information Follow IMCAS © 2026 IMCAS International Master Course on Aging Science. All rights reserved. Accessibility : non-compliant Processing, please wait... Error Please fill out all required fields. Here are the fields that are missing: OK IMCAS Search... Open menu Congresses IMCAS Asia 2026 19 - 21 June 2026 BANGKOK & ONLIN … us FAQ View our most Frequently Asked Questions Contact How can we help? IMCAS Fund Membership Sign in en IMCAS Close menu Congresses Academy Community About Membership IMCAS Asia 2026 19 - 21 June 2026, BANGKOK & ONLINE IMCAS China 2026 27 - 29 August 2026, SHANGHAI IMCAS World 2027 28 - 30 January 2027, PARIS & ONLINE IMCAS Americas 2027 20 - 22 May 2027, SãO PAULO INVEST by IMCAS 2027 January 27th, 2027, PARIS Webinars Live and on-demand access to the latest in aesthetic
CellFoam(TM) technology explained on Channel 10 | BioChange Ltd. posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to L
Happy new year! | BioChange Ltd. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , and Cookie Policy .
Biochange2 Toggle navigation Invest Ayalon invest NEW Raise Capital About us עברית Login Sign Up Your message was sent successfully Your request has been received. A company representative will contact you shortly. Your request has been received. A company representative will contact you shortly. BioChange Growing younger BioChange‘s mission is to increase healthy lifespan, restore body functions and tissues lost with age and disease. BioChange has developed a breakthrough technology that will revolutionize regenerative medicine and tissue engineering. Share biochange.life 0 Days to go 207% of … d additional two patent families in national phase. Plus one provisional patent application. In-market product for the veterinary care BioChange’s has already brought to market a veterinary product that solves the unmet problem of canine urinary incontinence (VetFoam™). The product offers a minimally invasive treatment option with high success rates and no adverse events. It remodels the urethra to become thicker and more functional. Readouts from a veterinary cli … el, a BSc, MSc (molecular genomics, cum laude) from Technion, and post-doctoral fellowship in Biology (population molecular genetics), in Haifa University. Ophir Artzi CMO Heading the Center for Aesthetic Dermatology in Sourasky Medical Center (TA) and his successful private clinic. Renowned physician and opinion leader in his field. Expert in skin rejuvenation, dermal fillers, organizer of the SCAR international conference. Mauro Wjuniski Expert in dermatology marketing Form … eurs Raise Capital Scouters Legal Info Terms of Use Privacy Policy Risk Warning Proposal coordinator license Accessibility statement The financing rounds, made through the ExitValley platform, are in accordance with a model of statutory exemption from publishing a prospectus pursuant to sections 15A(A)(1) and 15A(A)(7) of the Israeli Securities Law - 1968. Under this model, the disclosure of detailed information on the company and information about the investment in each roun
Resources - quadraScope Ventures --> --> --> --> --> --> --> --> --> Skip links Skip to primary navigation Skip to content li > a"}'> Home Science Portfolio Team Videos LOGIN Toggle navigation Home Science Portfolio Team Videos Resources quadraScope is pioneering the field of rejuvenation medicine. View and read our latest webinars, interviews, and articles. Conferences Tutorials Interviews QUADSMaster December 9, 2023 Solving DNA mutations central to aging and disease – interview with Chris Bradley QUADSMaster September 7, 2023 Biomaterials for tissue regeneration – interview with Ishay Attar
Speakers – Advances in 3D Bioprinting Skip to content Menu Home Conference pictures Speakers Sponsorship Program Accommodation General Information Advances in 3D Bioprinting Advances in 3D Bioprinting September 10th - 12th, 2023 Haifa, Israel Keynote Speakers | Robert Langer MIT, USA Read more | Sarah Heilshorn Stanford, USA Read more | Georg Duda Charité University hospital, Berlin, Germany Read more | Adam Feinberg Carnegie Mellon University, Pitsburg USA Read more | Jason Burdick University of Colorado , USA Read more | Milica Radisic University of Toronto, Canada Read more | Matthias
Meet The Speakers - Biomed Israel 2027 Skip to content Biomed Israel 2027: The 25th National Life Science & Technology Week • May 18-20, 2027 Home About Us Privacy Policy Conference Welcome Letter Scientific Committee Meet The Speakers Meet The Moderators Daily Program Company Presentations Past Events Exhibition Sponsors and Exhibitors Start-Up Pavilion Satellite Events Registration Networking Publications Hotel Accommodations Contact Us Menu Home About Us Privacy Policy Conference Welcome Letter Scientific Committee Meet The Speakers Meet The Moderators Daily Program Company Presentation … More Michel Habib Co-Founder, Managing General Partner ALIVE Israel HealthTech Fund Read More Ittai Harel Managing Partner Pitango Venture Capital Read More Michelle Lynn-Hall, PhD Co-Founder & General Partner Entrée Bioventures Read More Michael Rice Founding Partner LifeSci Advisors Read More TLV Partners Shahar Tzafir Shahar Tzafrir Managing Partner Read More Raphaël Wisniewski Partner Andera Partners Read More Keynote Speakers Prof. Uri Alon Professor, Systems Biolog … & CEO Luma Biophotonics Read More Yaron Daniely, PhD General Partner aMoon Fund Read More Anat Katz Arotchas Chief Product Officer PinkStar Read More Yael Schneidman CEO AccUrine Read More Prof. Tomer Shlomi Managing Director MetaSight (Guardant Health Israel) Read More Manuela Vecsler, PhD VP Clinical & Scientific Affairs Ibex Medical Analytics Read More The Future of Aging: Where Longevity Meets Innovation Effie Arditi CEO Longevitix Read More Ishay Attar Chairman, … Spinodal Read More Gilad Glick VP JJDC MedTech Johnson & Johnson Innovation Fund Read More Rotem Kaynan CEO Curespec Read More Eitan Kyiet Co-CEO CardiacSense Read More Prof. Chaim Lotan, MD Professor of Internal Medicine (Cardiology), Director, Heart Institute Hadassah-Hebrew University Read More Shuki Porath CEO PhysioMap Read More Eyal Sandach CEO Quintra Medical Read More Shaping the Future of Personalized Nutrition: Evidence-Driven Science Meets Real-World Eden Beck … rson aMoon Ventures, The 8400 Health Network Read More Reut Shema Partner aMoon Fund Read More SUBSCRIBE TO OUR NEWSLETTER Full Name Email Country Company Name I understand and agree to the Terms & Conditions and Privacy Policy. I understand and agree to the Terms & Conditions and Privacy Policy. SIGN UP Accessibility statement Facebook-f Twitter
#biomaterials #periodontitis #regenerativemedicine #worldbiomaterialscongress #regum #cellfoam #wbc #wbc2024 | Ishay Attar | 24 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Co … Post Ishay Attar 2y Edited Report this post We won the BEST POSTER PRESENTATION AWARD! out of 1200 posters presented recently at the World Biomaterials Congress in Korea. Two years ago, leading researchers conducted a canine study comparing BioChange Ltd. ’s ReGum with standard care treatment for periodontal disease. The results, published in Frontiers, showed a 100% improvement using our product in recovering lost gingival tissue and bone. Even more experimental data was add … our employees Keren Sinik and Shani Attias Cohen . Receiving such a prestigious award is an encouraging acknowledgment of the scientific value of our work. #biomaterials #periodontitis #RegenerativeMedicine #WorldBiomaterialsCongress #regum #cellfoam #WBC #WBC2024 63 24 Comments Like Comment Share Copy LinkedIn Facebook X Haim Azhari 2y Report this comment בס"ד Very Nice Ishay When do you think it might be ready for clinical trials in humans? Like Reply 1 Reaction 2 
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
Today, our CEO, Ishay Attar presented at the MIXiii Health-Tech.IL - OIS track. Happy to be acknowledged as the winner of the best presentation in the track. | BioChange Ltd. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Rejec
Lifeboat Foundation Bios: Ishay Attar, MBA, MSc Skip to content Lifeboat Foundation: Safeguarding Humanity About Blog Boards Programs Reports Papers Donate Join Us Newsletter Quotes Store Press Releases Toggle sitemap Lifeboat Foundation Sitemap icon-search Main Areas Home About Boards Blog Programs Reports Papers Donate Join Us Newsletter Quotes Store Press Releases Current Programs AIShield AsteroidShield BioShield InfoPreserver InternetShield LifePreserver LifeShield Bunkers NanoShield ScientificFreedomShield SecurityPreserver Space Habitats X-Risks Network Cool Places A-PRIZE Ark I Blue Be … gs Outreach Partnerships Rosetta@Home Volunteer Work About Us Bitcoin Endowment Fund Boards Board of Directors Contact Us Donor List FAQ Finances Guardian Award Interactive Friendly AI Logo Memorial Board Mission Statement Procedures Staff Supplemental FAQ Timeline More Programs AlienShield AntimatterShield BioPreserver BlackHoleShield ClimateShield CommPreserver EnergyPreserver GammaRayShield NeuroethicsShield NuclearShield ParticleAcceleratorShield PersonalityPreserver Seed … ’s leading medical-technology incubators, funded by the Trendlines Israel Fund and supported by the Israeli Office of the Chief Scientist. During his tenure, he managed deal flow and screening for new investments, linking entrepreneurs with technology, service providers, and investors, and recruited and fostered the growth of 16 early-stage companies. Thanks to the success of the majority of those companies, the Misgav incubator became the leading incubator in the count
Service Centers Home About JETC - Justify Your Attendance - Marketing Tool Kits & Social Media Graphics 2023 Schedule - Keynote FAM Forum Warfighter Seminar Pre-Conference: CMMC 2.0 Workshop Pre-Conference: Joint Geospatial Engineering Seminar Micro Session Theater Exhibits Exhibit Sales Information Exhibit at JETC Exhibit FAQ Exhibit Map Exhibitor Service Center Sponsors Sponsorship Information Thank You Sponsors! Sessions Keynote Speakers FAM Forum Warfighter Seminar Pre-Conference: CMMC 2.0 Workshop Pre-Conference: Joint Geospatial Engineering Seminar Micro Session Theater PDH and AIA Credi
SipNose-topiramate: a potential novel approach to binge eating management | Journal of Eating Disorders | Springer Nature Link Skip to main content Advertisement BMC journals have moved to Springer Nature Link. Learn more about website changes. Account Menu Find a journal Publish with us Track your research Search Saved research Cart Home Journal of Eating Disorders Article SipNose-topiramate: a potential novel approach to binge eating management Research Open access Published: 26 June 2023 Volume 11 , article number 102 ( 2023 ) Cite this article You have full access to this open access artic … PDF Save article View saved research Journal of Eating Disorders Aims and scope Submit manuscript SipNose-topiramate: a potential novel approach to binge eating management Download PDF Ayala Kobo-Greenhut 1 na1 , Adit Zohar-Beja 2 na1 , Liron Hadar 3 , Lior Itzhaki 3 , Avraham Karasik 3 , Yoseph Caraco 4 , Hilel Frankenthal 5 , 6 , Daniel Shahaf 3 , Dana Ekstein 7 , 8 , Iris Shichor 3 na2 & … Eitan Gur 2 na2 Show authors 6563 Accesses 4 Citations 11 Altmetric 1 Mention Ex
JavaScript is disabled In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
%PDF-1.4 %���� 1 0 obj > endobj 3 0 obj > endobj 5 0 obj > stream x����� ՝��$��ɨGˈ_P�B+YiE~1?�4 v�g�v7������K�+�F��.�\i,1�4 ƴus�Q�A1��t� ��fl d-����{!&v�����*��]�Η��� �J`�y���Wt(���� P��Z�1��F^�� ��/X���-�w y%0���֢��.6�JLy��ڐWoQ���+�� o��/ �~�� ����q�ɇ�G��Փz�>��A9�=B��ؓ����n��v�KҸ�]��������W�D:b������Z��o�k���%v�&Wg\Q')R��Z�R��*����r�ְ�5��?�7���J�*w�^�z�ʟ������6Ί�ME�Y��mwGnn�i3َ�r��M�2}i�E ߇�����nx}��n��z� �ig���7ަ�}ld/��oVq�GuenԖ�&�^�E;(�(��� u����fLw4 �G��d� � �Q�Ǿ�4rw���H����Y9�����S�����,���� *��%aK��Q�黣�=5�4��]X�ԙW�*C�oJ��/�϶�X��%�+��q������P
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
#bnisymposium #bnisymposium #livescience #brainnoseinterface #innovationinhealthcare #medicalbreakthroughs #proteomics | Philipp E. Geyer LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking C
Neuro-Bio visits Munich for the Brain-Nose Symposium, hosted by Noselab! - NeuroBio Home About Us Our Science Our Pipeline Neuro-Bio Assets Our People Board Management Science Team Science Advisory Board Company Organogram Publications Investors Hear from our Investors FAQ’s News Supporters Work With Us Careers Industrial Placements Contact Select Page Neuro-Bio visits Munich for the Brain-Nose Symposium, hosted by Noselab! Our research scientists, Amy Lewis and Lois Glover , recently attended the Brain-Nose Symposium in Munich, hosted by Noselab . This two-day event offered exceptional insigh
Use of High-Resolution CT Imaging Data in Lung Cancer Drug Development: Measuring Progress | CancerNetwork --> --> News Global Bulletin All News FDA Approval Alert Women in Oncology Media Around the Practice Between the Lines Face Off From All Angles Meeting of the Minds OncView Podcasts Shorts Training Academy Treatment Algorithms with the Oncology Brothers Videos Conferences Publications All Journals Editorial Board For Authors Year in Review More Events Frontline Forum Satellite Sessions CME/CE Resources Awareness Month The Bispecifics Network Nurse Practitioners/Physician's Assistants … tcomes in large numbers of patients. Imaging Issues in Lung Cancer The specific application of imaging in lung cancer management is limited by significant unmet needs. Series of cases are required for imaging tool validation in each clinical management setting, and in these different settings, there are distinct challenges for image analysis. Tumor-node-metastasis (TNM) staging has been the cornerstone of defining patient prognosis and also provides a useful framework for dis … ussed progress in image-processing over the past year. This overview included a proposal for a minimum recommendation of CT acquisition parameters for future lung cancer clinical trials. He also discussed the development of an infrastructure to support an open database of patient-donated CT scans. The patient advocacy group, Lung Cancer Alliance, had completed a pilot project named “Give-A-Scan” with a small group of patients. In this project, patients donate their own CT sca
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
%PDF-1.5 %���� 7 0 obj >/Subtype/Link/C[0 0 1]/F 4/Border[0 0 0]/Rect[57 488 142.62 498]>> endobj 8 0 obj >/Subtype/Link/C[0 0 1]/F 4/Border[0 0 0]/Rect[57 388 253.16 398]>> endobj 9 0 obj >/Subtype/Link/C[0 0 1]/F 4/Border[0 0 0]/Rect[288.78 288 437.77 298]>> endobj 10 0 obj >stream x��W[s�VV���%u@f �4n�@�b��C�p3!�b@$C �t ��D$A����� �]I@�D�i�X �����1�(⇞�"+(L ��0� r s�F�"��*�L \F�ƈ���B- �j�U��+��U��T�F�"˼E��d C� �3��w�@�/F�|A���T�Z������v��p�utl�1/7�� ��[��� Q��J��y ؖ���'� bh�z�� x������/�(�'��Ʒ�t�z%\C���y�>��/ �6�?�*�W�t�9�G���{�n�Ea즨�f�о4��y�.q�?dc=�פ� ��� �� %��5= … ڛ�dhy� �->n� P?�W�� �| endstream endobj 70 0 obj > endobj 73 0 obj >stream application/postscript Garth Stewart JCN_PDF_Banner_v2 Adobe Illustrator CS6 (Windows) 2016-12-07T13:21:11+05:30 2016-12-07T13:21:12+05:30 2016-12-07T13:21:12+05:30 xmp.did:AB5B7A8148BCE611A097DC0D7C2921FB xmp.iid:AB5B7A8148BCE611A097DC0D7C2921FB uuid:6B0BCF7E552FDE11A7A8A6BFDC166230 uuid:6C0BCF7E552FDE11A7A8A6BFDC166230 uuid:6B0BCF7E552FDE11A7A8A6BFDC166230 uuid:6B0BCF7E552FDE11A7A8A6BFDC166230 c … 7E552FDE11A7A8A6BFDC166230 uuid:6B0BCF7E552FDE11A7A8A6BFDC166230 converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:AB5B7A8148BCE611A097DC0D7C2921FB 2016-12-07T13:21:12+05:30 Adobe Illustrator CS6 (Windows) / 1 False True 168.999848 10.000079 Millimeters Cyan Magenta Yellow Black Default Swatch Group 0 PANTONE 123 CV SPOT 100.000000 RGB 234 191 49 PANTONE 288 CV SPOT 100.000000 RGB 0 72 120 PANTONE 202 CV SPOT 100.000000 RGB 122 0 36 PANT … 30.000002 0.000000 0.000000 endstream endobj 72 0 obj > endobj 75 0 obj >stream application/postscript Shyneer S. WB_ko_30mm.eps Adobe Illustrator CS3 2012-12-26T10:21:48+05:30 2012-12-26T10:22:36+05:30 2012-12-26T10:22:36+05:30 uuid:13FAA399174FE211A9F99851277BD585 uuid:5AB3BA11184FE211A9F99851277BD585 uuid:12FAA399174FE211A9F99851277BD585 uuid:11FAA399174FE211A9F99851277BD585 converted from application/postscript to application/vnd.adobe.illustrator 1 False True 215.900000 … ) 2016-08-12T10:53:06+05:30 2016-08-12T10:53:05+05:30 2016-08-12T10:53:06+05:30 application/postscript Shyneer S. orchid_logo.eps uuid:645c43a3-feca-4153-b60b-9a2a9dfc6428 xmp.iid:6915BBD94C60E611AD72B662A92B5C94 xmp.did:6915BBD94C60E611AD72B662A92B5C94 saved xmp.iid:40338E756D63E411A01CE06922E7E506 2014-11-05T17:29:33+05:30 Adobe Illustrator CS4
I just came across the Rangeland... - Dr. Michael Apasiku Facebook Log In Dr. Michael Apasiku 's Post Dr. Michael Apasiku November 25, 2025 · Shared with Public I just came across the Rangeland Paleoecology Lab at New Mexico State University (USA). They are offering fully funded Master’s positions starting in Summer/Fall 2026. The lab studies how ecosystems change over time — including the effects of animals, climate, water, fire, and vegetation — using field research, biomolecular analysis, remote sensing, GIS, and ecological modeling. Funding package includes: ~$28,300 annual stipend Tu
Reisen Leipzig und Sachsen – Anbieter Nähe Kürzlich gesucht Bearbeiten pencil Alles löschen bin-1 Fertig check Angebotsanfrage Anfragenportal Werden Sie Lieferant account Anmelden Firmen - Lieferanten - Dienstleistungen Reisen Filter Versand aus Deutschland (266) In meiner Nähe Zurücksetzen Geben Sie Ihren Standort ein Meinen Standort verwenden Umkreis(km): 10 25 50 75 100 125 250 Kartenfilter Zurücksetzen Kartenansicht öffnen Lieferantentyp Hersteller/Fabrikant (120) Kundenspezifische Fertigung (11) Lieferant (74) Dienstleister (201) Großhändler (41) Mitarbeiter 1-4 (34) 5-9 (38) 10-19 (51) 2
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
SICCS postdoc supported by prestigious Marie Curie Fellowship Skip to content Ecological and Environmental Informatics Research Menu Home What We Do Who We Are Graduate Program INF PhD – Ecological and Environmental Informatics (EEI) emphasis area EEI Coursework Information INF Graduate Program Graduate Certificate in Ecological & Environmental Informatics Seminar and Events Schedule Opportunities Faculty and Staff Job Opportunities Research Opportunities Presidential Fellowship Undergraduate Program Collaborations SICCS postdoc supported by prestigious Marie Curie Fellowship Andrew … Doughty’s Megabiota lab , was recently awarded a Marie Curie postdoctoral fellowship to work at Aarhus University, Denmark. Andrew will work with Dr Elizabeth le Roux (https://bio.au.dk/en/research/research-centres/biochange) to develop an ecological model that can accurately quantify the transport of nutrients by animals living in diverse landscapes across the world. The model will first be validated in southern Africa, where animal communities include predators, scave … forefront of this... Read More August 20, 2021 Incoming T3 Student Awarded NSF Fellowship Incoming PhD Student, Natasha Wesely was awarded an NSF Graduate Research Fellowship (NSF-GRFP). Her proposal, entitled "Hierarchical Controls of Landform... Read More August 20, 2021 25 Years of Carbon Cycle Measurements at Howland Forest Professor Andrew Richardson (SICCS and Ecoss) and BIO PhD student Aaron Teets (BIO) recently co-authored a paper that analyzed 25... Read More August
%PDF-1.4 %���� 575 0 obj > endobj 621 0 obj >stream 2022-03-28T14:57:38Z Word 2026-06-26T05:35:25-07:00 2026-06-26T05:35:25-07:00 macOS Version 11.2 (Build 20D64) Quartz PDFContext application/pdf MOSAIC: A Unified Trait Database to Complement Structured Population Models uuid:9c48c0f5-1dd1-11b2-0a00-6a0927fd5800 uuid:9c48c0f8-1dd1-11b2-0a00-6a0000000000 endstream endobj 574 0 obj > endobj 5 0 obj > endobj 334 0 obj > endobj 331 0 obj > endobj 366 0 obj > endobj 399 0 obj > endobj 445 0 obj > endobj 477 0 obj > endobj 504 0 obj > endobj 542 0 obj > endobj 541 0 obj >/ExtGState >/Font >/ProcSet … �κ�[�UɎ{6�ך [���-���߱CvlZ��K��j�������f�3Є� j �,��]E Wz������������[ 1�뜲&�rFp� بIF�l i�^o 9��^�W��>�/��M���~�M9�K^�K��6ET{��h�%�5T�ZE�%b ��@/b4=h��;b �(�����/��d"nc]�]{���Ę}��lTW� h:w��}�l��y�)cL�N[�]OK���YG�ʡ���4W�.��W%��#́F�U�.��� #���T& M���R�����; �S��{PV.F\݄�E)�}�u>��G\R��F�X��V���\7�o�]��l,� ��fq�\����X���p��`^ #P���? ���1���b�]���W�{����d�"4�h������l�e�.�v _��1c�g� ���4�: ,�X� ]K��s�m`��|�vQ/�c�ҽ�+i���������?g0�>�[��w�2����쓳��Xz�x����VV�� … �κ�[�UɎ{6�ך [���-���߱CvlZ��K��j�������f�3Є� j �,��]E Wz������������[ 1�뜲&�rFp� بIF�l i�^o 9��^�W��>�/��M���~�M9�K^�K��6ET{��h�%�5T�ZE�%b ��@/b4=h��;b �(�����/��d"nc]�]{���Ę}��lTW� h:w��}�l��y�)cL�N[�]OK���YG�ʡ���4W�.��W%��#́F�U�.��� #���T& M���R�����; �S��{PV.F\݄�E)�}�u>��G\R��F�X��V���\7�o�]��l,� ��fq�\����X���p��`^ #P���? ���1���b�]���W�{����d�"4�h������l�e�.�v _��1c�g� ���4�: ,�X� ]K��s�m`��|�vQ/�c�ҽ�+i���������?g0�>�[��w�2����쓳��Xz�x����VV��
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Resources - quadraScope Ventures --> --> --> --> --> --> --> --> --> Skip links Skip to primary navigation Skip to content li > a"}'> Home Science Portfolio Team Videos LOGIN Toggle navigation Home Science Portfolio Team Videos Resources quadraScope is pioneering the field of rejuvenation medicine. View and read our latest webinars, interviews, and articles. Conferences QUADSMaster January 1, 2026 Longevity Nation 2025 QUADSMaster June 30, 2023 Foresight Institute Longevity Frontiers Workshop 2023 QUADSMaster November 17, 2022 Master Investor 2022 Tutorials QUADSMaster December 30, 2025 Tutori
QUADSMaster, Author at quadraScope Ventures --> --> --> --> --> --> --> --> Skip links Skip to primary navigation Skip to content li > a"}'> Home Science Portfolio Team Videos LOGIN Toggle navigation Home Science Portfolio Team Videos Longevity Nation 2025 QUADSMaster January 1, 2026 quadraScope will be attending JPM Healthcare Week QUADSMaster December 30, 2025 Tutorial on mitochondrial dysfunction QUADSMaster December 30, 2025 Tutorial on chronic inflammation QUADSMaster December 30, 2025 BioChange – transforming tissue regeneration QUADSMaster December 30, 2025 quadraScope spoke at the Buck
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
SALT Conference 🚀 Together with James... - Viktoriya Tigipko Facebook Log In Viktoriya Tigipko's Post Viktoriya Tigipko September 14, 2021 · Shared with Public SALT Conference Together with James Peyer - Founder and CEO of Cambrian Biopharma, the company developing therapeutics targeting the biology of ageing. Cambrian builds, finances, and manages a pipeline of therapeutics (14 companies now ). TAVentures and ICLUB are pleased to support the company since the very beginning! As investors and longevity topic believers, we are happy with the results All reactions: 241 9 comments 1 share L
We are thrilled to share that Prof. Tzipi Strauss, Director of the Neonatal Department and Head of Sheba’s Longevity Center, will soon be heading to Davos, Switzerland, to represent the field of longevity on two of the world’s most prestigious stages: the World Economic Forum and the Future Health Forum! 🇨🇭 It is a huge honor for all of us at Sheba to see Prof. Strauss bringing the "Israel Model" to the global stage, proving how cutting-edge longevity science can be successfully integrated into a healthcare system to benefit patients... - Global Patient Services at Sheba Medical Ce
BGRF - 🚀 Showcasing Israel's Top Longevity Industry... Facebook Log In BGRF's Post BGRF April 30, 2023 · Shared with Public Showcasing Israel's Top Longevity Industry Influencers: Entrepreneurs Edition In collaboration with Longevity.International, Deep Knowledge Group, and Aging Analytics Agency with support of Vetek Association - the Movement for Longevity and Quality of Life, ATLAS Advocacy and Biogerontology Research Foundation, we're excited to continue highlighting the 𝐓𝐎𝐏 𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐜𝐞𝐫𝐬 in the Longevity Industry in Israel , with a focus on entrepreneurs w
%PDF-1.7 %���� 1 0 obj >/OutputIntents[ >] /Metadata 16003 0 R/ViewerPreferences 16004 0 R>> endobj 2 0 obj > endobj 3 0 obj >/ExtGState >/XObject >/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 595.32 841.92] /Contents 4 0 R/Group >/StructParents 0>> endobj 4 0 obj > stream x���[k�0�� �ߥ=���J!�6�h`#�]�^x��;� F��,7�k�P7�r��ϲ�>z%�r4,��c����"VU�xJ�p ���!���i�-�VyR�� > endobj 6 0 obj > endobj 7 0 obj > endobj 8 0 obj > endobj 9 0 obj > stream ����JFIF����ZExifMM*JQQQ������C ��C … endobj 499 0 obj > endobj 16003 0 obj >stream Microsoft® Word for Microsoft 365 application/pdf Couturiaux, Danielle (CSI - Social Research & Information Division) Arolwg Cenedlaethol Cymru Holiadur peilot 2026-27 2026-01-06T15:03:29Z Microsoft® Word for Microsoft 365 2026-01-07T08:43:39Z 2026-01-07T08:43:39Z uuid:4ac479c6-3158-4230-ac22-69fbab296065 uuid:bda58c5e-5ae8-4021-beab-9b92c8ff767e endstream endobj xref 0 1 0000000000 65535 f 3 1 0002991198 00000 n 14 1 00029915
Lifeboat Foundation What’s New – Lifeboat Foundation Skip to content Lifeboat Foundation: Safeguarding Humanity About Blog Boards Programs Reports Papers Donate Join Us Newsletter Quotes Store Press Releases Toggle sitemap Lifeboat Foundation Sitemap icon-search Main Areas Home About Boards Blog Programs Reports Papers Donate Join Us Newsletter Quotes Store Press Releases Current Programs AIShield AsteroidShield BioShield InfoPreserver InternetShield LifePreserver LifeShield Bunkers NanoShield ScientificFreedomShield SecurityPreserver Space Habitats X-Risks Network Cool Places A-PR … gs Outreach Partnerships Rosetta@Home Volunteer Work About Us Bitcoin Endowment Fund Boards Board of Directors Contact Us Donor List FAQ Finances Guardian Award Interactive Friendly AI Logo Memorial Board Mission Statement Procedures Staff Supplemental FAQ Timeline More Programs AlienShield AntimatterShield BioPreserver BlackHoleShield ClimateShield CommPreserver EnergyPreserver GammaRayShield NeuroethicsShield NuclearShield ParticleAcceleratorShield PersonalityPreserver Seed … alysis to yield unnerving flashes of the future.” — William Gibson, award-winning author of Neuromancer . Jun 18 2026 Read Atomically precise mechanosynthesis of carbon structures on hydrogenated Si(100) by inverted-mode STM , coauthored by our Damian G. Allis . Jun 18 2026 Read ‘Human, all too human’: Will we become hostages to our own minds by implementing universal AI? by our Ariel VA Feinerman . Jun 18 2026 Watch The Physics of FTL Travel by our Is … r Planet is Entering a New Era by our Victor V. Motti . Jun 14 2026 Yuta Aoki , Application Scientist at Matlantis , joins our Physics Board. Jun 14 2026 Christopher Lee Jones , author of Mars Mission I: Surviving the Kessler Effect , joins our Space Settlement Board. Jun 14 2026 Ghanim Alotaibi , Cofounder of the Advance Space Civilization Initiative (ASCI) , joins our Space Settlement Board. Jun 14 2026 Eligar Sadeh , Chief Editor of the academic journal Astropolitics , joi … hat will resonate with all reader—Dorothie and Marty Hellman persuasively apply their life lessons to the domain of foreign affairs. “We are often puzzled when peoples of two nations seem to get along, while their governments are at loggerheads. The Hellmans have much to say about why this does not have to be so.”—A
Aging Companies (for profits) - Google Sheets Die Datei kann in Ihrem Browser nicht geöffnet werden, weil JavaScript nicht aktiviert ist. Aktivieren Sie JavaScript und laden Sie die Seite noch einmal. Diese Browserversion wird nicht mehr unterstützt. Installieren Sie bitte einen unterstützten Browser. Aging Companies (for profits) Tab Extern Freigeben Anmelden Datei Bearbeiten Ansicht Einfügen Format Daten Tools Erweiterungen Hilfe Bedienungshilfen Fehlerbehebung Nicht gespeicherte Änderungen in Drive &n … NA interference (RNAi) therapieus to silence disease-specific genes, with broad application to many age-related disease areas FDA approved Tx proteostasis (h)ATTR(-CM), AD, HD, ALS, T2D, MASH, NAFLD, hypercholesterolemia, hypertension humans 82 ATTR, APP, PCSK9, AGT, HTT, SOD-1, HSD17B13 siRNA pharma Yvonne Greenstreet, Kevin Fitzgerald Boston yes ALNY $39,142 2100 2442 2002 >$100M Onpattro, Amvuttra, Leqvio science presentations 2025-02-02 2024-08-15 *Borderline: Broad pr
Ilia Stambler - In exactly 3 months! On 28-29 October... Facebook Log In Ilia Stambler's Post Ilia Stambler July 28, 2025 · Shared with Public In exactly 3 months! On 28-29 October 2025, there takes place the Longevity Nation conference, in Bar-Ilan University, Israel. https://longevitynation.org/ The preliminary conference program: https://longevitynation.org/program/ You are invited! Attendance is free, but registration is required: https://longevitynation.org/register-and-donate/ Grateful for spreading the word and grateful for support of our conference! +4 All reactions: 17 11 shares
bioch4nge - Renewable Gas Show Go to content Side event: International Congress of Bioenergy → +34 975 10 20 20 LinkedIn Main menu Home Exhibitor Info Visitor Info Thinking of visiting us? Professional Accreditation International Congress of Bioenergy Advance List of Exhibitors 2026 News past editions 2025 edition 2024 edition 2023 edition Get in Touch +34 975 10 20 20 biochange AB Energy will install a new BIOCH4NGE® unit in Navarra to produce biomethane News / May 27th 2026 AB Energy, global sponsor of the Renewable Gas Show, has begun installing a new BIOCH4NGE® unit in Navarre. This biogas